Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CR3294 for prevention of chemotherapy-induced mucositis in autologous stem cell transplant patients
2010-020660-37Phase 2Terminated
- Sponsor
- Rottapharm Biotech
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stomatitis and gastrointestinal mucositis comparing CR3294 with Placebo (2 arms). Primary endpoint: Incidence of oral mucositis grade 3 and 4. Started Jul 2010; status: terminated.
02
Drugs
CR3294
03
Conditions
stomatitisgastrointestinal mucositis
Beyond the preview
Go deeper on 2010-020660-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020660-37.